TUCSON, Ariz., Aug. 8, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the successful completion of its WAVE ...

The current market for breast implants is estimated at $2.6 billion a year CollPlant (CLGN) expects the study to conclude by the first half of 2024 CollPlant plans to use findings from this study and ...

We could be on the verge of a major cancer treatment breakthrough, with a new vaccine shown to completely obliterate pancreatic cancer cells in preclinical trials. This paves the way for it to move ...

An executive order upended an NIH policy requiring researchers to account for both sexes in preclinical animal studies.

Accelerate Diagnostics, Inc. AXDX recently announced the completion of the pre-clinical trial of its WAVE system. The WAVE pre-clinical trial showed strong performance, along with strong instrument ...

A research team from Virginia Commonwealth University has found that a drug currently in clinical trials for brain disorders such as Alzheimer's disease might also have potential for treating alcohol ...

A drug used to treat insomnia has protected mice against the buildup of the tau protein found to clump abnormally in neurodegenerative diseases like Alzheimer's. This could lead to new ways to help ...

To be published in The Journal of Allergy and Clinical Immunology, Molekule’s research will highlight compelling methods for pet dander destruction “Indoor air quality is of the utmost importance to ...

A UC San Diego lab recently announced a pair of scientific breakthroughs for Pitt-Hopkins and Rett syndromes that are slated for government-approved clinical trials soon. The approvals by the U.S.